Patient Experience With Uncovered/Restricted Medications

Analyses are based on a sample of 3,000 participants from October 2024 through December 2024. Percentages and participant counts in the second chart reflect responses from participants who indicated "Yes" to the first question. Percentages and participant counts in the third chart reflect responses from participants who indicated "Yes" to the second question.
GoodRx (yellow logo)